[1]
“CLINICAL ENDOCANNABINOID DEFICIENCY (CED): A THEORETICAL FRAMEWORK AND THE THERAPEUTIC POTENTIAL OF MEDICAL CANNABIS IN NEUROIMMUNE AND PSYCHIATRIC DISORDERS”, ISJM, vol. 4, no. 4, p. e7855 , Aug. 2025, doi: 10.56238/isevmjv4n4-032.